drugset / Trial / NCT00176995

Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae

NCT00176995

Phase 2 Completed 15 enrolled Hordinsky, Maria K., MD
Non-randomizedSingle-groupOpen-labelEct

Summary

This trial is designed to gain insight into the mechanism of action of eflornithine hydrochloride in men and to aid in determining if this compound is deserving of further development for a pseudofolliculitis barbae indication. This study will also provide knowledge which will be useful in designing future PFB trials in this indication is pursued.

Timeline

Start
1999-03
Primary completion
Completion
2000-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Eflornithine Small molecule 15 % Topical